Review on CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
TM Tzschentke - Addiction biology, 2007 - Wiley Online Library
Conditioned place preference (CPP) continues to be one of the most popular models to
study the motivational effects of drugs and non‐drug treatments in experimental animals …
study the motivational effects of drugs and non‐drug treatments in experimental animals …
Endogenous opiates and behavior: 2005
RJ Bodnar, GE Klein - Peptides, 2006 - Elsevier
This paper is the 28th consecutive installment of the annual review of research concerning
the endogenous opioid system, now spanning over a quarter-century of research. It …
the endogenous opioid system, now spanning over a quarter-century of research. It …
Treatment of nausea and vomiting: gaps in our knowledge
GJ Sanger, PLR Andrews - Autonomic neuroscience, 2006 - Elsevier
The past 20 years have seen notable advances in our understanding of the physiology and
pharmacology of the emetic reflex leading to the identification of the anti-emetic effects of 5 …
pharmacology of the emetic reflex leading to the identification of the anti-emetic effects of 5 …
Metabotropic receptors for glutamate and GABA in pain
C Goudet, V Magnaghi, M Landry, F Nagy… - Brain research …, 2009 - Elsevier
Glutamate and γ-amino butyric acid (GABA) are respectively two major excitatory and
inhibitory neurotransmitters of the adult mammalian central nervous system. These …
inhibitory neurotransmitters of the adult mammalian central nervous system. These …
Nausea and the quest for the perfect anti-emetic
PLR Andrews, GJ Sanger - European journal of pharmacology, 2014 - Elsevier
The discovery of anti-emetic agents is reviewed to illustrate the large database (> 129,000
papers in PubMed) available for potential data mining and to provide a background to the …
papers in PubMed) available for potential data mining and to provide a background to the …
GABAB receptors in reward processes
S Vlachou, A Markou - Advances in pharmacology, 2010 - Elsevier
Abstract γ-aminobutyric acid (GABA) is the predominant inhibitory neurotransmitter in the
brain which acts through different receptor subtypes. Metabotropic GABA B receptors are …
brain which acts through different receptor subtypes. Metabotropic GABA B receptors are …
Neurochemical mechanisms and pharmacologic strategies in managing nausea and vomiting related to cyclic vomiting syndrome and other gastrointestinal disorders
M Bashashati, RW McCallum - European journal of pharmacology, 2014 - Elsevier
Nausea and vomiting are common gastrointestinal complaints which could be triggered by
stimuli in both the peripheral and central nervous systems. They may be considered as …
stimuli in both the peripheral and central nervous systems. They may be considered as …
[PDF][PDF] Combination opioid analgesics
HS Smith - Pain physician, 2008 - painphysicianjournal.com
Although there is no “ideal analgesic,” scientists and clinicians alike continue to search for
compounds with qualities which may approach the “ideal analgesic.” Characteristics of an …
compounds with qualities which may approach the “ideal analgesic.” Characteristics of an …
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents
L Fattore, MS Spano, G Cossu, M Scherma… - European …, 2009 - Elsevier
The γ-aminobutyric acid (GABA)-B receptor agonist baclofen is known to reduce drug intake
in both animals and humans and to prevent reinstatement of cocaine-, opioid-, and alcohol …
in both animals and humans and to prevent reinstatement of cocaine-, opioid-, and alcohol …
A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting
J Sato, R Tanaka, H Ishikawa, T Suzuki… - Supportive Care in …, 2020 - Springer
Background Opioid-induced nausea and vomiting (OINV) is induced by opioid receptor
stimulation of chemoreceptor trigger zones and vestibular apparatus by opioids …
stimulation of chemoreceptor trigger zones and vestibular apparatus by opioids …